GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 89 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,961,000 | +4.1% | 160,182 | +0.4% | 0.00% | 0.0% |
Q3 2016 | $1,883,000 | +40.4% | 159,599 | +3.6% | 0.00% | 0.0% |
Q2 2016 | $1,341,000 | +69.3% | 154,094 | +2.6% | 0.00% | +100.0% |
Q1 2016 | $792,000 | -30.7% | 150,195 | +1.9% | 0.00% | 0.0% |
Q4 2015 | $1,143,000 | -0.9% | 147,358 | +0.6% | 0.00% | -50.0% |
Q3 2015 | $1,153,000 | -15.3% | 146,524 | -2.5% | 0.00% | 0.0% |
Q2 2015 | $1,362,000 | -13.6% | 150,283 | +23.8% | 0.00% | 0.0% |
Q1 2015 | $1,576,000 | -3.8% | 121,391 | +0.8% | 0.00% | 0.0% |
Q4 2014 | $1,639,000 | +50.9% | 120,396 | -0.5% | 0.00% | 0.0% |
Q3 2014 | $1,086,000 | -32.8% | 121,021 | +1.2% | 0.00% | 0.0% |
Q2 2014 | $1,617,000 | +63.8% | 119,531 | +20.4% | 0.00% | +100.0% |
Q1 2014 | $987,000 | -23.8% | 99,276 | +1.9% | 0.00% | -50.0% |
Q4 2013 | $1,295,000 | +7.4% | 97,467 | -1.9% | 0.00% | 0.0% |
Q3 2013 | $1,206,000 | +54.4% | 99,369 | +31.7% | 0.00% | +100.0% |
Q2 2013 | $781,000 | – | 75,437 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 950,000 | $9,823,000 | 1.01% |
Curi RMB Capital, LLC | 939,265 | $9,720,000 | 0.74% |
KOPP INVESTMENT ADVISORS LLC | 96,384 | $997,000 | 0.39% |
Alyeska Investment Group, L.P. | 314,502 | $3,254,000 | 0.16% |
PFM Health Sciences, LP | 604,199 | $6,252,000 | 0.13% |
Spark Investment Management LLC | 47,000 | $485,000 | 0.13% |
ELLINGTON MANAGEMENT GROUP LLC | 61,700 | $638,000 | 0.12% |
PUTNAM INVESTMENTS LLC | 1,745,494 | $18,048,000 | 0.05% |
PointState Capital LP | 298,976 | $3,094,000 | 0.05% |
Partner Investment Management, L.P. | 20,717 | $214,000 | 0.05% |